For the twelve months ended Jun 30, 2026, DNA X Inc. reported -$8.55M of net income.
SONM revenue was $16.21M in fiscal Q3 2025 (ended Sep 30, 2025), up 7.9% from a year earlier and up 44.9% from the prior quarter. For the full fiscal 2024 it was $58.30M, down 37.7% from fiscal 2023. Compound annual growth was -12.9% over 5 years. It rose in 2 of the last 6 fiscal years.
SONM net income was -$1.25M in fiscal Q2 2026 (ended Jun 30, 2026), compared with -$7.47M a year earlier. For the full fiscal 2025 it was -$20.66M, compared with -$33.65M in fiscal 2024.
SONM diluted EPS was -$0.92 in fiscal Q2 2026 (ended Jun 30, 2026). For the full fiscal 2025 it was -$28.58.
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | - | $58.30M | $93.63M | $69.83M | $54.57M | $63.99M | $116.25M | $135.66M |
| Cost of revenue | - | $48.38M | $74.31M | $58.20M | $48.16M | $48.78M | $81.74M | $87.58M |
| Gross profit | - | $9.92M | $19.32M | $11.62M | $6.41M | $15.21M | $34.51M | $48.09M |
| Research and development | - | $14.23M | $1.77M | $7.97M | $17.70M | $16.22M | $26.06M | $23.25M |
| Selling, general and admin | $5.41M | $3.10M | $8.27M | $10.67M | $10.28M | $9.83M | $15.09M | $7.22M |
| Operating income | -$5.41M | -$3.10M | $513.0K | -$14.29M | -$38.00M | -$29.26M | -$22.38M | $5.39M |
| Interest expense | $945.0K | - | - | $97.0K | - | - | - | - |
| Pre-tax income | -$7.96M | -$2.88M | $284.0K | -$13.90M | -$38.46M | -$30.45M | -$24.45M | $2.03M |
| Income tax | -$1.15M | $226.0K | $374.0K | $184.0K | $167.0K | -$521.0K | $1.39M | $754.0K |
| Net income | -$20.66M | -$33.65M | -$90.0K | -$14.09M | -$38.63M | -$29.93M | -$25.83M | $1.28M |
| EPS, basic | -$28.58 | -$128.37 | -$0.36 | -$8.82 | -$73.44 | -$116.64 | -$25.02 | -$46.26 |
| EPS, diluted | -$28.58 | -$128.37 | -$0.36 | -$8.82 | -$73.44 | -$116.64 | -$25.02 | -$46.26 |
| Diluted shares | 722,689 | 262,118 | 238,205.222 | 1.6M | 525,808.889 | 256,714.167 | 1.0M | 191,515.722 |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $1.30M | $5.34M | $9.40M | $13.21M | $11.23M | $22.14M | $11.30M | $13.05M |
| Receivables | - | $4.34M | $25.30M | $22.43M | $10.80M | $4.15M | $10.08M | $18.88M |
| Inventory | - | $10.62M | $6.52M | $3.91M | $5.54M | $11.34M | $19.53M | $21.83M |
| Current assets | $28.91M | $32.16M | $43.79M | $43.63M | $35.69M | $45.57M | $47.34M | $63.87M |
| Total assets | $43.90M | $39.74M | $56.04M | $53.69M | $41.09M | $50.31M | $55.46M | $67.34M |
| Current liabilities | $50.63M | $43.74M | $32.15M | $32.06M | $20.98M | $20.47M | $27.61M | $48.20M |
| Short-term debt | $5.07M | - | - | $147.0K | $148.0K | $177.0K | $9.82M | $301.0K |
| Long-term debt | - | - | - | - | $66.0K | $185.0K | $362.0K | $13.21M |
| Total debt | $5.07M | - | - | $147.0K | $214.0K | $362.0K | $10.18M | $13.51M |
| Total liabilities | $50.63M | $45.44M | $33.67M | $33.64M | $22.46M | $21.90M | $29.93M | $62.22M |
| Shareholders' equity | -$7.96M | -$5.70M | $22.37M | $20.05M | $18.63M | $28.41M | $25.52M | $5.13M |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$23.53M | -$8.49M | -$4.05M | -$12.36M | -$38.48M | -$10.56M | -$33.52M | $3.86M |
| Capital expenditures | - | $214.0K | $36.0K | $8.0K | $46.0K | $11.0K | $992.0K | $787.0K |
| Free cash flow | - | -$8.70M | -$4.09M | -$12.37M | -$38.52M | -$10.57M | -$34.52M | $3.07M |
| Investing cash flow | - | -$214.0K | -$36.0K | -$8.0K | -$46.0K | -$11.0K | -$1.36M | -$2.54M |
| Financing cash flow | $19.49M | $4.65M | $272.0K | $14.35M | $27.61M | $21.41M | $33.13M | $10.15M |
| Stock-based compensation | $1.54M | $1.52M | $1.50M | $1.55M | $1.08M | $1.09M | $6.31M | $252.0K |
| Depreciation and amortization | $4.30M | $3.56M | $2.21M | $2.38M | $2.13M | $2.73M | $3.52M | $1.85M |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | - | -37.7% | 34.1% | 28.0% | -14.7% | -45.0% | -14.3% | - |
| Gross margin | - | 17.0% | 20.6% | 16.6% | 11.8% | 23.8% | 29.7% | 35.4% |
| Operating margin | - | -5.3% | 0.5% | -20.5% | -69.6% | -45.7% | -19.3% | 4.0% |
| Net margin | - | -57.7% | -0.1% | -20.2% | -70.8% | -46.8% | -22.2% | 0.9% |
| Free cash flow margin | - | -14.9% | -4.4% | -17.7% | -70.6% | -16.5% | -29.7% | 2.3% |
| Return on equity | - | - | -0.4% | -70.3% | -207.3% | -105.4% | -101.2% | 24.9% |
| Return on assets | -47.1% | -84.7% | -0.2% | -26.2% | -94.0% | -59.5% | -46.6% | 1.9% |
| Current ratio | 0.57 | 0.74 | 1.36 | 1.36 | 1.70 | 2.23 | 1.71 | 1.33 |
| Debt to equity | - | - | - | 0.01 | 0.01 | 0.01 | 0.40 | 2.63 |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | $16.21M | $11.19M | $16.72M | $14.98M | $15.02M | $11.52M | $16.78M | $13.43M | $27.57M |
| Cost of revenue | - | - | - | $14.40M | $10.35M | $8.37M | $15.17M | $10.79M | $8.55M | $13.87M | $8.31M | $21.96M |
| Gross profit | - | - | - | $1.82M | $845.0K | $8.36M | -$183.0K | $4.23M | $2.97M | $2.90M | $5.12M | $5.60M |
| Research and development | - | - | - | $181.0K | $909.0K | $1.63M | $12.51M | $715.0K | $557.0K | $456.0K | $926.0K | $741.0K |
| Selling, general and admin | $1.28M | $3.62M | -$3.82M | $3.16M | $1.47M | $870.0K | -$4.84M | $2.85M | $2.45M | $2.64M | $2.40M | $2.04M |
| Operating income | -$1.28M | -$3.62M | $4.66M | -$3.98M | -$1.47M | -$870.0K | $8.44M | -$2.38M | -$6.47M | -$2.69M | -$1.25M | $688.0K |
| Interest expense | - | $131.0K | $374.0K | $339.0K | $161.0K | $71.0K | - | - | - | - | - | $2.0K |
| Pre-tax income | -$1.24M | -$3.93M | $3.45M | -$4.66M | -$1.86M | -$961.0K | $8.87M | -$2.40M | -$6.58M | -$2.78M | -$1.26M | $623.0K |
| Income tax | -$243.0K | $2.54M | -$1.51M | $90.0K | $138.0K | $132.0K | -$53.0K | $117.0K | $37.0K | $125.0K | $93.0K | $96.0K |
| Net income | -$1.25M | $6.34M | -$8.89M | -$4.75M | -$7.47M | $458.0K | -$21.61M | -$2.51M | -$6.62M | -$2.91M | -$1.35M | $527.0K |
| EPS, basic | -$0.92 | $5.01 | - | -$4.83 | -$14.15 | $1.41 | -$81.97 | -$9.32 | -$25.38 | -$11.70 | - | $2.16 |
| EPS, diluted | -$0.92 | $5.01 | - | -$4.83 | -$14.15 | $1.41 | -$81.97 | -$9.32 | -$25.38 | -$11.70 | - | $2.16 |
| Diluted shares | 1.4M | 1.3M | - | 984,927 | 528,367 | 324,431 | - | 269,388 | 260,297.333 | 246,562.833 | - | 245,445.889 |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $900.0K | $1.20M | $1.30M | $2.14M | $2.01M | $2.12M | $5.34M | $9.06M | $9.60M | $9.25M | $9.40M | $9.80M |
| Receivables | $1.25M | $1.50M | - | $3.50M | $2.87M | $4.85M | $4.34M | $5.24M | $8.13M | $7.52M | $25.30M | $30.35M |
| Inventory | - | - | - | $10.99M | $9.89M | $8.62M | $10.62M | $12.37M | $7.02M | $4.82M | $6.52M | $4.22M |
| Current assets | $2.92M | $3.30M | $28.91M | $30.30M | $27.12M | $26.93M | $32.16M | $33.86M | $32.59M | $29.54M | $43.79M | $47.54M |
| Total assets | $4.52M | $4.84M | $43.90M | $40.22M | $36.08M | $35.96M | $39.74M | $49.15M | $45.87M | $42.38M | $56.04M | $58.61M |
| Current liabilities | $5.15M | $4.32M | $50.63M | $38.86M | $35.66M | $34.68M | $43.74M | $32.18M | $26.89M | $20.98M | $32.15M | $34.04M |
| Short-term debt | - | $1.07M | $5.07M | $4.82M | $2.92M | $2.27M | - | - | - | - | - | $37.0K |
| Long-term debt | - | - | - | $250.0K | - | $566.0K | - | - | - | - | - | - |
| Total debt | - | $1.07M | $5.07M | $5.07M | $2.92M | $2.83M | - | - | - | - | - | - |
| Total liabilities | $5.75M | $4.92M | $50.63M | $40.92M | $37.41M | $37.04M | $45.44M | $33.80M | $28.40M | $22.55M | $33.67M | $35.50M |
| Shareholders' equity | -$1.23M | -$983.0K | -$7.96M | -$701.0K | -$1.33M | -$1.08M | -$5.70M | $15.35M | $17.47M | $19.84M | $22.37M | $23.11M |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$2.00M | -$3.47M | -$2.00M | -$7.03M | -$4.88M | -$9.61M | -$4.51M | -$417.0K | -$3.39M | -$168.0K | -$351.0K | -$304.0K |
| Capital expenditures | - | - | - | - | - | - | $8.0K | $137.0K | $39.0K | $30.0K | $12.0K | $1.0K |
| Free cash flow | - | - | - | - | - | - | -$4.52M | -$554.0K | -$3.43M | -$198.0K | -$363.0K | -$305.0K |
| Investing cash flow | -$94.0K | $3.36M | - | - | - | - | -$8.0K | -$137.0K | -$39.0K | -$30.0K | -$12.0K | -$1.0K |
| Financing cash flow | - | - | $1.17M | $7.17M | $4.77M | $6.38M | $800.0K | $14.0K | $3.78M | $53.0K | -$37.0K | $382.0K |
| Stock-based compensation | $98.0K | $304.0K | $159.0K | $166.0K | $926.0K | $290.0K | $356.0K | $373.0K | $472.0K | $324.0K | $458.0K | $371.0K |
| Depreciation and amortization | - | - | $1.50M | $952.0K | $797.0K | $1.05M | $914.0K | $918.0K | $845.0K | $880.0K | $956.0K | $67.0K |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | - | - | - | 7.9% | -2.8% | -0.3% | 11.6% | -45.5% | -57.1% | -35.0% | -44.3% | 34.5% |
| Net income growth, YoY | - | 1284.3% | - | - | - | - | - | - | - | - | - | - |
| Gross margin | - | - | - | 11.2% | 7.6% | 50.0% | -1.2% | 28.2% | 25.8% | 17.3% | 38.1% | 20.3% |
| Operating margin | - | - | - | -24.5% | -13.1% | -5.2% | 56.3% | -15.8% | -56.2% | -16.0% | -9.3% | 2.5% |
| Net margin | - | - | - | -29.3% | -66.8% | 2.7% | -144.2% | -16.7% | -57.5% | -17.3% | -10.1% | 1.9% |
| Free cash flow margin | - | - | - | - | - | - | -30.1% | -3.7% | -29.8% | -1.2% | -2.7% | -1.1% |
| Current ratio | 0.57 | 0.76 | 0.57 | 0.78 | 0.76 | 0.78 | 0.74 | 1.05 | 1.21 | 1.41 | 1.36 | 1.40 |
Source: XBRL data DNA X Inc. files with the SEC, latest filing dated Aug 19, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures and share counts are restated for stock splits the filings show: 1-for-18, first reported Oct 31, 2025.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| SONM | - | - | -$8.55M | - | $3.5M |
| VZ | $139.39B | +1.4% | $16.42B | 11.8% | $191.94B |
| TMUS | $93.82B | +9.3% | $11.30B | 12.0% | $179.10B |
| T | $128.85B | +3.5% | $13.13B | 10.2% | $147.76B |
| GLW | $17.72B | +18.8% | $2.24B | 12.6% | $96.58B |
| AMX | MXN 943.64B | +8.6% | MXN 82.82B | 8.8% | $77.52B |
| LITE | $3.74B | +103.2% | -$6.58B | -175.8% | $53.11B |
| CIEN | $6.02B | +32.6% | $654.41M | 10.9% | $38.59B |
| CHT | NT$236.11B | +2.7% | NT$38.70B | 16.4% | $37.86B |